Role of Circulating Cell-free DNA Levels in Patients With Severe Preeclampsia and HELLP Syndrome

Isolated abducens nerve palsy in preeclampsia and hypertension in pregnancy

(2013) Antonio J Vallejo-Vaz et al.   HYPERTENSION RESEARCH

Cell-free Nucleic Acids as Potential Markers for Preeclampsia

(2011) S. Hahn et al.   PLACENTA

The HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): Clinical characteristics and maternal–fetal outcome in 172 patients

(2011) M.L. Miranda et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

Pathogenesis of Preeclampsia

(2010) Brett C. Young et al.   Annual Review of Pathology-Mechanisms of Disease

Association of cell-free plasma DNA with perioperative mortality in patients with suspected acute mesenteric ischemia

(2010) Francisco Arnalich et al.   CLINICA CHIMICA ACTA

The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke

(2010) Nai-Wen Tsai et al.   CLINICA CHIMICA ACTA

Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy

(2010) Apostolos Zaravinos et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Quantification of Circulating Cell-Free DNA in the Serum of Patients with Obstructive Sleep Apnea–Hypopnea Syndrome

(2010) Liang Ye et al.   LUNG

Quantity of total cell free and cell free fetal DNA in pregnancies with no complications and with preeclampsia

(2010) Levente Lázár et al.   ORVOSI HETILAP

Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia

(2009) Levente Lazar et al.   BMC Medical Genetics

Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism

(2009) Juliana A. Uzuelli et al.   CLINICA CHIMICA ACTA